Philips’ ADAC Laboratories and Elekta Oncology Systems have entered a global alliance to offer hospitals a clinical radiotherapy solution. The alliance will strive to integrate ePinnacle, a radiotherapy treatment planning system, with the Elekta
Philips’ ADAC Laboratories and Elekta Oncology Systems have entered a global alliance to offer hospitals a clinical radiotherapy solution. The alliance will strive to integrate ePinnacle, a radiotherapy treatment planning system, with the Elekta Precise Treatment System digital platform. The partnership encompasses joint marketing, sales, support, and development programs.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.